Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Results from a Phase III trial met the criteria for non-inferiority and superiority compared to piperacillin/tazobactam in the primary outcome of clinical cure and microbiological eradication in patients with complicated UTIs
In pivotal clinical trials, these agents typically reduce hemoglobin A1c by 0.81.5% from baseline, with greater reductions observed at higher doses and in patients with higher baseline A1c values
This three-hour buffer allows time for food to digest properly, especially as lying down right after eating can cause acid reflux to move back up into the esophagus, causing discomfort
The LEADER trial for liraglutide and SUSTAIN-6 for semaglutide established cardiovascular benefit for that class
Non-injectable sterile cosmetic for professional topical use, with a pharmaceutical-grade formulation, free from preservatives and additives
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
